A detailed history of Moody National Bank Trust Division transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Moody National Bank Trust Division holds 3,661 shares of VRTX stock, worth $1.84 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,661
Previous 3,688 0.73%
Holding current value
$1.84 Million
Previous $1.73 Million 1.5%
% of portfolio
0.18%
Previous 0.14%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$460.0 - $505.78 $12,420 - $13,656
-27 Reduced 0.73%
3,661 $1.7 Million
Q2 2024

Jul 03, 2024

BUY
$392.81 - $485.53 $43,601 - $53,893
111 Added 3.1%
3,688 $1.73 Million
Q1 2024

Apr 04, 2024

BUY
$407.69 - $446.08 $4,484 - $4,906
11 Added 0.31%
3,577 $1.5 Million
Q4 2023

Jan 11, 2024

SELL
$343.0 - $410.68 $1.01 Million - $1.21 Million
-2,952 Reduced 45.29%
3,566 $1.45 Million
Q3 2023

Oct 12, 2023

BUY
$338.18 - $362.46 $273,587 - $293,230
809 Added 14.17%
6,518 $2.27 Million
Q2 2023

Jul 07, 2023

BUY
$314.42 - $351.91 $18,865 - $21,114
60 Added 1.06%
5,709 $2.01 Million
Q1 2023

Apr 19, 2023

SELL
$283.23 - $323.1 $2,265 - $2,584
-8 Reduced 0.14%
5,649 $1.78 Million
Q4 2022

Jan 11, 2023

BUY
$285.76 - $321.48 $2,571 - $2,893
9 Added 0.16%
5,657 $1.63 Million
Q2 2022

Jul 07, 2022

SELL
$234.96 - $292.55 $153,663 - $191,327
-654 Reduced 10.38%
5,648 $1.59 Million
Q1 2022

Apr 12, 2022

SELL
$221.42 - $260.97 $175,807 - $207,210
-794 Reduced 11.19%
6,302 $1.64 Million
Q4 2021

Jan 13, 2022

SELL
$177.01 - $223.45 $3.96 Million - $5 Million
-22,379 Reduced 75.93%
7,096 $1.56 Million
Q3 2021

Oct 07, 2021

SELL
$181.39 - $202.99 $3,446 - $3,856
-19 Reduced 0.06%
29,475 $5.35 Million
Q2 2021

Jul 13, 2021

SELL
$187.49 - $221.1 $70,121 - $82,691
-374 Reduced 1.25%
29,494 $5.95 Million
Q1 2021

Apr 14, 2021

BUY
$207.02 - $241.31 $21,116 - $24,613
102 Added 0.34%
29,868 $6.42 Million
Q4 2020

Mar 04, 2021

BUY
$207.01 - $276.09 $24,220 - $32,302
117 Added 0.39%
29,766 $7.04 Million
Q2 2020

Jul 10, 2020

BUY
$225.48 - $295.8 $21,420 - $28,101
95 Added 0.32%
29,649 $8.61 Million
Q3 2019

Oct 18, 2019

BUY
$166.23 - $187.09 $14,129 - $15,902
85 Added 0.29%
29,554 $5.01 Million
Q1 2019

Apr 11, 2019

BUY
$163.73 - $194.7 $2,455 - $2,920
15 Added 0.05%
29,469 $5.42 Million
Q4 2018

Jan 07, 2019

BUY
$151.91 - $192.21 $27,191 - $34,405
179 Added 0.61%
29,454 $4.88 Million
Q3 2018

Oct 31, 2018

BUY
$167.73 - $192.74 $4.45 Million - $5.12 Million
26,560 Added 978.27%
29,275 $5.64 Million
Q1 2018

Apr 16, 2018

BUY
$151.6 - $177.13 $213,301 - $249,221
1,407 Added 107.57%
2,715 $442,000
Q4 2017

Jan 18, 2018

BUY
$137.28 - $155.55 $179,562 - $203,459
1,308
1,308 $417,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Moody National Bank Trust Division Portfolio

Follow Moody National Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.